NCT06963216View on ClinicalTrials.gov

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Acquired Factor X Deficiency
Interventions
BIOLOGICAL

Coagadex(R)

Coagulation Factor X (Human)

Sponsors

Collaborators (1)

Worldwide Clinical Trials
All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

lead

Kedrion S.p.A.

INDUSTRY